Andere Sprachen BRAIN Biotech AG Deutsche Boerse AG

Aktien

520394

DE0005203947

BNN

Realtime-Estimate Tradegate Andere Börsenplätze 19:08:27 11.06.2024			% 5 Tage	% 1. Jan.
2.785 ^EUR	+1.27%		0.00%	-23.82%

28.05.	BRAIN Biotech AG gibt Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. März 2024 bekannt	CI
05.03.	BRAIN Biotech AG und AMSilk GmbH geben den erfolgreichen Abschluss der ersten Phase einer Entwicklungszusammenarbeit bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes	29.05.
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	28.05.
BRAIN Biotech : receives major milestone payment and stays on-track to achieve year end targets	28.05.
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets	28.05.
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	14.05.
Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	16.04.
BRAIN Biotech AG takes next step to optimize group structure	16.04.
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams	14.03.
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG	12.03.
Collaboration between BRAIN Biotech and AMSilk, Protein engineering successfully improves structural proteins for performance materials	06.03.
BRAIN Biotech : Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying	05.03.
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials	05.03.
BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	05.03.
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives	29.02.
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights	29.02.
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	28.02.
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24	28.02.
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2023	17.01.
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy	17.01.
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	10.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BRAIN Biotech AG Deutsche Boerse AG

Aktien

520394

DE0005203947

BNN

Andere Sprachen

Filter